Markus Möhler

Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With <i>KRAS</i> Wild-Type Tumors in Metastatic Colorectal Cancer

Dominik Paul Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal et al. · Journal of Clinical Oncology · 2015 · 123 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma.

Antonia Dimitrakopoulou‐Strauss, Ludwig G. Strauss, P. Schlag et al. · PubMed · 1998 · 71 citations

Medicine, Oncology, Pharmacology +14

Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)

S-E. Al-Batran, Claudia Pauligk, Nils Homann et al. · Annals of Oncology · 2017 · 42 citations

Medicine, Oncology, Surgery +11

Sequence elements of the adeno-associated virus rep gene required for suppressionof herpes-simplex-virus-induced DNA amplification

Jürgen A. Kleinschmidt, Markus Möhler, Friedrich W. Weindler et al. · Virology · 1995 · 33 citations

Life Sciences, Genetics, Molecular Biology +12

Case Report: Primary Hepatic High-Grade Non-Hodgkin's Lymphoma and Chronic Hepatitis C Infection

Markus Möhler, F. Gutzler, B. Kallinowski et al. · Digestive Diseases and Sciences · 1997 · 32 citations

Medicine, Oncology, Pathology +13